POSA107 Apixaban Versus Other Anticoagulants in the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation: A Comparison of All-Cause and Event-Related Costs in Real-Life Setting in France
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.251
https://www.valueinhealthjournal.com/article/S1098-3015(21)02046-5/fulltext
Title :
POSA107 Apixaban Versus Other Anticoagulants in the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation: A Comparison of All-Cause and Event-Related Costs in Real-Life Setting in France
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02046-5&doi=10.1016/j.jval.2021.11.251
First page :
Section Title :
Open access? :
No
Section Order :
11022